A 3-Dimensional Approach to Detecting & Treating Cancer
GeneNews (TSX: GEN, GNWS-OTC) is a cancer diagnostics company focused on bringing traditional and genomic-based clinical laboratory tests to market. Our innovative cancer diagnostic tests provide physicians with personalized clinical intelligence to improve health outcomes through early diagnosis of disease, guiding treatment and monitoring remission.
GeneNews' mission is to build a pipeline of tests that will help practitioners get a more complete, three dimensional view of patient health in order to identify, treat and monitor cancer effectively.
Personalized Medicine: How labs must prepare for genomic-based tests for cancer
by Karl Wassmann, Executive
Vice President U.S. Corporate Development